Abstract:A local field isolate of MDV named YL040920 was isolated from a commercial Three-Yellow chicken flock,which had been vaccinated with CVI988/Rispens vaccine and experienced significant MD visceral tumors,by transfecting monolayer of duck embryo fibroblast(DEF) with the peripheral blood lymphocytes(PBLs) of the bird.Nine individual clones of the isolate obtained by plaque assay were identical in the time of plaque formation and shape of plaques that demonstrated the purity of the isolate.The oncogenicity-related gene meq of the isolate was amplified by polymerase chain reaction(PCR) technique,and then was sequenced and compared with that of the other reference strains of MDV-1.The isolate was found to have the sequence characteristics of virulent MDV-1.Specific fluorescent staining localized in the nuclei of the infected DEFs by an immunofluorescence assay(FA) using an anti-MEQ monoclonal antibody 3G12E6.Xiayan chicks were challenged with the isolate and obvious tumors were observed at about PI 21d,showing the acute oncogenicity of the isolate.And among all the organs,heart,liver and skin had the highest tumor occurrences.The results of t-test showed that in term of the mortality and tumor occurrence,chickens of general line were significantly higher than those of chickens of MD resistant line(P0.05),however there were no significant difference between the vaccinated and unvaccinated chickens with HVT(P0.05).A developed differential diagnosis technique based on a multiplex PCR for avian neoplastic diseases was used to detect the DNA prepared from the virus infected DEFs and tumor samples of the challenged birds,the characteristic patterns of electrophoresis of the virulent MDV-1 were observed from all the samples detected,but were negative for detection of reticuloendotheliosis virus(REV) and avian leucosis virus(ALV).The results of the study demonstrated that isolate YL040920,proved to be a pure virulent virus of MDV-1 and free of CVI988 virus,reticuloendotheliosis virus (REV) and avian leucosis virus(ALV),posscesses the ability to cause acute tumors which mainly ocurred in heart,liver and skin.

Development of monoclonal antibodies against Marek's disease virus

Expression and preparation of polyclonal antibody of L-meq gene of Marek′s disease virus

Development of Hybridoma Cell Strains Excreting Monoclonal Antibody Against BVDV

The Development of Monoclonal Antibody(mcab) Against MEQ Protein of Marek's Disease Virus(mdv) and Its Applications

Efficient Cross-Screening and Characterization of Monoclonal Antibodies Against Marek's Disease Specific Meq Oncoprotein Using CRISPR/Cas9-Gene-Edited Viruses.

Fusion Expression and Purification of Marek's Disease Virus Tegument Protein VP16 and Its Antibody Preparation

Rapid Production of Monoclonal Antibodies from Single Mouse B Cells Against FMDV

Preparation and Identification of Monoclonal Antibodies Against MATSA

Development and characterization of a novel specific monoclonal antibody against mink enteritis virus and its antigen epitope analysis

Development of Two Potential Diagnostic Monoclonal Antibodies Against Human Cytomegalovirus Glycoprotein B

Preparation of Monoclonal Antibodies Against Duck Enteritis Virus

Isolation and Identification of a Field Isolate of Marek's Disease Virus with Acute Oncogenicity

A New Strategy for Efficient Screening and Identification of Monoclonal Antibodies against Oncogenic Avian Herpesvirus Utilizing CRISPR/Cas9-Based Gene-Editing Technology

Early Detection of Oncogenic and Pathogenic Serotype I Marek's Disease Virus

Preparation and identification of monoclonal antibodies against locale isolated strain of duck hepatitis virus

Development and Characterization of Monoclonal Antibodies Against VP1 Protein of O Type Foot-and-mouth Disease Virus

DEVELOPMENT AND APPLICATION OF TWO DIAGNOSTIC TECHNIQUES ON MAREK’S DISEASE

Prokaryotic Expression of the Partial Gb Gene of the Marek’s Disease Virus

Preparation and Specificity Analysis of Monoclonal Antibodies Against Newcastle Disease Virus

Preparation of monoclonal antibodies against N protein of equine arteritis virus

Generation and Characterization of Monoclonal Antibodies Against Canine Distemper Virus.